ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Nuclear Nonproliferation Policy
The mission of the Nuclear Nonproliferation Policy Division (NNPD) is to promote the peaceful use of nuclear technology while simultaneously preventing the diversion and misuse of nuclear material and technology through appropriate safeguards and security, and promotion of nuclear nonproliferation policies. To achieve this mission, the objectives of the NNPD are to: Promote policy that discourages the proliferation of nuclear technology and material to inappropriate entities. Provide information to ANS members, the technical community at large, opinion leaders, and decision makers to improve their understanding of nuclear nonproliferation issues. Become a recognized technical resource on nuclear nonproliferation, safeguards, and security issues. Serve as the integration and coordination body for nuclear nonproliferation activities for the ANS. Work cooperatively with other ANS divisions to achieve these objective nonproliferation policies.
Meeting Spotlight
ANS Student Conference 2025
April 3–5, 2025
Albuquerque, NM|The University of New Mexico
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Apr 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
May 2025
Nuclear Technology
April 2025
Fusion Science and Technology
Latest News
First astatine-labeled compound shipped in the U.S.
The Department of Energy’s National Isotope Development Center (NIDC) on March 31 announced the successful long-distance shipment in the United States of a biologically active compound labeled with the medical radioisotope astatine-211 (At-211). Because previous shipments have included only the “bare” isotope, the NIDC has described the development as “unleashing medical innovation.”
Deniz Canbula, Bora Canbula
Nuclear Technology | Volume 209 | Number 6 | June 2023 | Pages 895-901
Technical Paper | doi.org/10.1080/00295450.2022.2163802
Articles are hosted by Taylor and Francis Online.
Some isotopes such as 123I and 124I are useful in medical science, and thus, the production of these isotopes has great importance. Iodine-123 is the gamma-emitting radioisotope of radioiodine, and 124I is the long-lived positron-emitting radioisotope of radioiodine, and they have applications in diagnosis via both Single Photon Emission Computed Tomography (SPECT)/Positron Emission Tomography (PET) and radiotherapy. Therefore, many theoretical and experimental studies are performed for these isotopes. In this study, the cross sections of the 123Te(p,n), 124Te(p,n), and 124Te(p,2n) reactions up to 31 MeV, where 123I and 124I can be produced, are calculated by importing the Collective Semi-Classical Fermi Gas Model (CSCFGM) to the Talys 1.96 computer code. The predictions are compared with the default theoretical calculations of Talys 1.96 and existing experimental data taken from the EXFOR library. The results are in good agreement with the experimental data, and therefore, CSCFGM looks to be a useful tool for predicting the production reactions of some therapeutic isotopes.
